US 7612107
Treatment and inhibition of disease conditions using flexible heteroarotinoids
granted A61KA61K31/38A61K31/382
Quick answer
US patent 7612107 (Treatment and inhibition of disease conditions using flexible heteroarotinoids) held by The Board of Regents of the University of Oklahoma expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/38, A61K31/382, A61P, A61P1/16